Third Arc Bio Emerges with $165 Million to Innovate in Solid Tumors and Autoimmune Diseases A team of Johnson & Johnson veterans launched Third Arc Bio with $165 million in [….]
Third Arc Bio Emerges with $165 Million to Innovate in Solid Tumors and Autoimmune Diseases A team of Johnson & Johnson veterans launched Third Arc Bio with $165 million in [….]